Robison L.S.
52
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Farmacología | 4 |
| Fisiología | 4 |
| Neuropsicología | 3 |
| Neurología | 1 |
| Biomedicina | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 6 |
| Fisiología humana | 4 |
| Enfermedades | 4 |
| Temas específicos de historia natural de los animales | 2 |
| Microorganismos, hongos y algas | 1 |
| Bioquímica | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| David Edward Komatsu | 7 |
| Thanos P.K. | 7 |
| Hadjiargyrou M. | 7 |
| Volkow N.D. | 2 |
| Swanson J.M. | 2 |
| Hamilton J. | 2 |
| Ananth M. | 2 |
| Fricke D. | 2 |
| Steier J. | 1 |
| Hwang Y. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats
ArticleAbstract: Previously, we created an 8-h limited-access dual bottle drinking paradigm to deliver methylphenidatPalabras claves:dopamine, methylphenidate, Psychostimulant, Reward deficiency syndrome, reward, addiction, TransporterAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Robison L.S., Thanos P.K.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopusMethylphenidate regulation of osteoclasts in a dose- A nd sex-dependent manner adversely affects skeletal mechanical integrity
ArticleAbstract: Methylphenidate (MP) is the most prescribed psychostimulant for ADHD patients, with clinically demonPalabras claves:Autores:Chernoff E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Robison L.S., Thanos P.K., Uddin S.M.Z.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusA pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopus